#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 48

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Chronic cutaneous lupus erythematosus+2

Not recruiting

Investigational

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Litifilimab

Contact Research Centre

Spinal muscular atrophy

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety and Effects of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Trials

InvestigationalNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Apitegromab

Contact Research Centre

Hormone receptor positive breast cancer

Not recruiting

Registered drugNo placebo

Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study of Imlunestrant, Fulvestrant, Exemestane, and Abemaciclib for Patients with Advanced Estrogen Receptor Positive, HER2 Negative Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drug

Study of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Mrna-4157

Contact Research Centre

Amyotrophic lateral sclerosis

Not recruiting

Investigational

Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Utreloxastat

Contact Research Centre

Acromegaly

Not recruiting

InvestigationalNo placebo

Study of long-term safety of octreotide subcutaneous depot (CAM2029) in patients with acromegaly

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Octreotide Hydrochloride

Contact Research Centre

Neuroblastoma+4

Not recruiting

Registered drugNo placebo

Study on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months - 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Ribociclib

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drug

Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drug

Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Fibrodysplasia ossificans progressiva

Not recruiting

Investigational

Study on the Effects of Fidrisertib for Treating Fibrodysplasia Ossificans Progressiva in Children and Adults

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:(R)‑Tetrahydrofuran‑3‑Yl 4‑(6‑(5‑(4‑Ethoxy‑1‑Isopropylpiperidin‑4‑Yl)Pyridin-2-Yl)Pyrrolo[1,2-B]Pyridazin-4-Yl)Piperazine-1-Carboxylate Sesquisuccinate

Contact Research Centre

Cystic fibrosis

Not recruiting

Investigational

Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Dirocaftor

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.